vimarsana.com

Page 4 - கற்றலான் நிறுவனம் ஆஃப் புற்றுநோயியல் News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Red meat intake, poor education linked to colorectal cancer

A new paper in JNCI Cancer Spectrum, published by Oxford University Press, indicates that several non-genetic factors including greater red meat intake, lower educational attainment, and heavier alcohol use are associated with an increase in colorectal cancer in people under 50. In the United States, incidence rates of early-onset colorectal cancer have nearly doubled between 1992 and 2013 (from 8.6 to 13.1 per 100,000), with most of this increase due to early-onset cancers of the rectum. Approximately 1 in 10 diagnoses of colorectal cancer in this country occur in people under 50. Researchers have observed the rise particularly among people born since the 1960s in studies from the United States, Canada, Australia, and Japan. During the same period there have been major changes in diets among younger generations across the developing world. Such changes include decreases in consumption of fruits, non-potato vegetables, and calcium-rich dairy sources. This is coupled with an incre

New Test Predicts Tumors Most Likely to Respond to Radiation, Chemotherapy

Immunovia s PanFAM-1 Prospective Study Gathers Over 3000 Familial Hereditary Pancreatic Cancer Risk Samples And Will Be Analysed In The Second Half Of 2021

Share this article Share this article LUND, Sweden, Feb. 15, 2021 /PRNewswire/ According to the American Cancer Society, as many as 10% of pancreatic cancers are caused by familial and hereditary risk factors. PanFAM-1 is the largest prospective study to date, focusing on early diagnosis in high-risk individuals with Familial/Hereditary Pancreatic Cancer (FPC). Designed to support the road to reimbursement for Immunovia s blood test, IMMray™ PanCan-d, the study has ended enrollment of new subjects October 30, 2020 from the 23 familial/hereditary pancreatic cancer high-risk surveillance programs in USA and Europe. The study reports the collection of over 3000 blood samples from 1265 subjects. The last blood samples will be collected in April 2021. All blood samples will be analysed in the second half of 2021.

Big data analysis finds cancer s key vulnerabilities

 E-Mail NEW YORK, NY (Jan. 11, 2021) Thousands of different genetic mutations have been implicated in cancer, but a new analysis of almost 10,000 patients found that regardless of the cancer s origin, tumors could be stratified in only 112 subtypes and that, within each subtype, the Master Regulator proteins that control the cancer s transcriptional state were virtually identical, independent of the specific genetic mutations of each patient. The study, published Jan. 11 in Cell, confirms that Master Regulators provide the molecular logic that integrates the effect of many different and patient-specific mutations to implement the transcriptional state of a specific tumor subtype, thus greatly expanding the fraction of patients who may respond to the same treatment.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.